MD Pediatrix Medical Company Profit

Official company branding of Pediatrix Medical Group, Inc. (MD)

The price action of Pediatrix Medical (MD) reflects the current 0.18 indicator. The neonatology care leader is currently updating its management and divesting non-core assets to reduce debt. Revenue growth is constrained by the need to recruit high-cost specialists, as physicians, rather than software, serve as the primary cash generator. Meanwhile, extensive coverage across US clinics creates a reliable defensive barrier, although a labor shortage is hindering expansion.

Pediatrix Corp (MD) - Company Net Income from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for MEDNAX (MD)

- stock value and consensus price forecast:
Market Price Pediatrix|MD - Price Target Chart
- market capitalization data:
Market Capitalization Pediatrix Corp|MD - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share Pediatrix Medical Group|MD - Company Book Value|Market Capitalization to Net Assets mednax.com|MD - Company Total Assets
- debt and solvency information:
Debt to Capital Pediatrix Medical|MD - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Pediatrix Corp|MD - Company Aggregate Debts|Debts to Net Assets Pediatrix Corp|MD - Company Long-Term Debts|Company Short-Term Debts Pediatrix Medical Group|Intermediate Liquidity Ratio mednax.com
- earnings and valuation multiples indicators:
MD - Company Net Income
Fundamental valuation:MD - mednax.com
Signature product of mednax.com

Pediatrix Medical (MD) operates in a protected sector where an aging population guarantees stable demand. This indicator digitizes the net residual funds per share after deducting all expenses. The metric captures the real balance of market forces, reflecting the current efficiency of the operating model. It is critical for investors to correlate this data with the industry cycle phase. Analyzing the dynamics of the company's financial results confirms the strategy's resilience to macroeconomic shocks.

Direct competitors

Company Net Income HCA Healthcare (HCA)|Company Net Income Tenet Healthcare|Company Profit FMS (freseniusmedicalcare.com)|Net Income SOLV (Solventum)|Profit After Payment of Taxes EHC|Company Net Income Universal Health Services, Inc. UHS|DVA (DaVita Corp) - Profit After Tax|RadNet, Inc. - Net Profit|Company Net Income optioncarehealth.com|SGRY: Net Profit|Company Profit PINC|EYE (National Vision Corp) - Net Profit|Progyny Corp (PGNY) - Net Financial Result|Net Profit ARDT|Net Profit selectmedical.com (SEM)|Astrana Health - Net Income|Profit After Payment of Taxes USPH (US Physical Therapy)|PNTG - Company Net Income|Final Profit ORGO (Organogenesis Corp)|NUTX: Net Profit|AUNA - Net Financial Result|Net Income SBC|Company Profit EOLS (Evolus Inc)|Net Income CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Final Profit|Company Net Income MediWound MDWD|BTMD - Net Income|The Joint Chiropractic - Net Profit|Company Net Income DocGo, Inc.|PIII: Net Profit|Company Profit GANX|EUDA (EUDA Health) - Net Profit|Basel Medical Group Limited (BMGL) - Net Financial Result|Net Profit CLGN|Net Income Cuprina Holdings (Cayman) Ltd. CUPR|Net Profit CCM (Concord Medical Services Holdings Limited)|Net Profit ASHS AMS|MRM - Company Net Income|ALBT: Company Net Income|DIH Holding (DHAI) - Company Net Income|Net Income Carmell Therapeutics Corporation|NIVF (NewGenIvf Group Ltd) - Net Profit|Company Profit ATIP (ATI Physical Therapy Corp)|Net Income CMAX (CareMax, Inc.)|Profit After Payment of Taxes KDLY|Company Net Income ModivCare MODV|Final Profit NVOS|SunLink Health Systems, Inc - Net Profit|Company Net Income IMAC Corp